BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 25200956)

  • 1. STAT1 signaling is essential for protection against Cryptococcus neoformans infection in mice.
    Leopold Wager CM; Hole CR; Wozniak KL; Olszewski MA; Wormley FL
    J Immunol; 2014 Oct; 193(8):4060-71. PubMed ID: 25200956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT1 signaling within macrophages is required for antifungal activity against Cryptococcus neoformans.
    Leopold Wager CM; Hole CR; Wozniak KL; Olszewski MA; Mueller M; Wormley FL
    Infect Immun; 2015 Dec; 83(12):4513-27. PubMed ID: 26351277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective immunity against pulmonary cryptococcosis is associated with STAT1-mediated classical macrophage activation.
    Hardison SE; Herrera G; Young ML; Hole CR; Wozniak KL; Wormley FL
    J Immunol; 2012 Oct; 189(8):4060-8. PubMed ID: 22984078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-17 is not required for classical macrophage activation in a pulmonary mouse model of Cryptococcus neoformans infection.
    Hardison SE; Wozniak KL; Kolls JK; Wormley FL
    Infect Immun; 2010 Dec; 78(12):5341-51. PubMed ID: 20921149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis.
    Wozniak KL; Ravi S; Macias S; Young ML; Olszewski MA; Steele C; Wormley FL
    PLoS One; 2009 Sep; 4(9):e6854. PubMed ID: 19727388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary infection with an interferon-gamma-producing Cryptococcus neoformans strain results in classical macrophage activation and protection.
    Hardison SE; Ravi S; Wozniak KL; Young ML; Olszewski MA; Wormley FL
    Am J Pathol; 2010 Feb; 176(2):774-85. PubMed ID: 20056835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CARD9 Is Required for Classical Macrophage Activation and the Induction of Protective Immunity against Pulmonary Cryptococcosis.
    Campuzano A; Castro-Lopez N; Martinez AJ; Olszewski MA; Ganguly A; Leopold Wager C; Hung CY; Wormley FL
    mBio; 2020 Jan; 11(1):. PubMed ID: 31911495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Th2 but not Th1 immune bias results in altered lung functions in a murine model of pulmonary Cryptococcus neoformans infection.
    Jain AV; Zhang Y; Fields WB; McNamara DA; Choe MY; Chen GH; Erb-Downward J; Osterholzer JJ; Toews GB; Huffnagle GB; Olszewski MA
    Infect Immun; 2009 Dec; 77(12):5389-99. PubMed ID: 19752036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robust Th1 and Th17 immunity supports pulmonary clearance but cannot prevent systemic dissemination of highly virulent Cryptococcus neoformans H99.
    Zhang Y; Wang F; Tompkins KC; McNamara A; Jain AV; Moore BB; Toews GB; Huffnagle GB; Olszewski MA
    Am J Pathol; 2009 Dec; 175(6):2489-500. PubMed ID: 19893050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of IL-17A on resolution of pulmonary C. neoformans infection.
    Wozniak KL; Hardison SE; Kolls JK; Wormley FL
    PLoS One; 2011 Feb; 6(2):e17204. PubMed ID: 21359196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-γ immune priming of macrophages in vivo induces prolonged STAT1 binding and protection against Cryptococcus neoformans.
    Leopold Wager CM; Hole CR; Campuzano A; Castro-Lopez N; Cai H; Caballero Van Dyke MC; Wozniak KL; Wang Y; Wormley FL
    PLoS Pathog; 2018 Oct; 14(10):e1007358. PubMed ID: 30304063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cytokine interplay on macrophage polarization during chronic pulmonary infection with Cryptococcus neoformans.
    Arora S; Olszewski MA; Tsang TM; McDonald RA; Toews GB; Huffnagle GB
    Infect Immun; 2011 May; 79(5):1915-26. PubMed ID: 21383052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-13 induces disease-promoting type 2 cytokines, alternatively activated macrophages and allergic inflammation during pulmonary infection of mice with Cryptococcus neoformans.
    Müller U; Stenzel W; Köhler G; Werner C; Polte T; Hansen G; Schütze N; Straubinger RK; Blessing M; McKenzie AN; Brombacher F; Alber G
    J Immunol; 2007 Oct; 179(8):5367-77. PubMed ID: 17911623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced innate immune responsiveness to pulmonary Cryptococcus neoformans infection is associated with resistance to progressive infection.
    Guillot L; Carroll SF; Homer R; Qureshi ST
    Infect Immun; 2008 Oct; 76(10):4745-56. PubMed ID: 18678664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryptococcal heat shock protein 70 homolog Ssa1 contributes to pulmonary expansion of Cryptococcus neoformans during the afferent phase of the immune response by promoting macrophage M2 polarization.
    Eastman AJ; He X; Qiu Y; Davis MJ; Vedula P; Lyons DM; Park YD; Hardison SE; Malachowski AN; Osterholzer JJ; Wormley FL; Williamson PR; Olszewski MA
    J Immunol; 2015 Jun; 194(12):5999-6010. PubMed ID: 25972480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dectin-2 deficiency promotes Th2 response and mucin production in the lungs after pulmonary infection with Cryptococcus neoformans.
    Nakamura Y; Sato K; Yamamoto H; Matsumura K; Matsumoto I; Nomura T; Miyasaka T; Ishii K; Kanno E; Tachi M; Yamasaki S; Saijo S; Iwakura Y; Kawakami K
    Infect Immun; 2015 Feb; 83(2):671-81. PubMed ID: 25422263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective immunity against experimental pulmonary cryptococcosis in T cell-depleted mice.
    Wozniak KL; Young ML; Wormley FL
    Clin Vaccine Immunol; 2011 May; 18(5):717-23. PubMed ID: 21450975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-25 Receptor Signaling Modulates Host Defense against
    Hansakon A; Jeerawattanawart S; Pattanapanyasat K; Angkasekwinai P
    J Immunol; 2020 Aug; 205(3):674-685. PubMed ID: 32561567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of IFN-gamma in regulating T2 immunity and the development of alternatively activated macrophages during allergic bronchopulmonary mycosis.
    Arora S; Hernandez Y; Erb-Downward JR; McDonald RA; Toews GB; Huffnagle GB
    J Immunol; 2005 May; 174(10):6346-56. PubMed ID: 15879135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of IL-22 and antimicrobial peptide production in mice protected against pulmonary Cryptococcus neoformans infection.
    Wozniak KL; Hole CR; Yano J; Fidel PL; Wormley FL
    Microbiology (Reading); 2014 Jul; 160(Pt 7):1440-1452. PubMed ID: 24760968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.